Cutisma™ - Intensive Medical-Grade Demelanising Solution

Cutisma™ is a protocol-driven, in-clinic depigmentation system developed for complex and recurrent pigmentation disorders. It combines regenerative and depigmenting actives in a two-phase vial system, allowing controlled sequencing of skin repair followed by pigment suppression. The formulation addresses melanocyte hyperactivity, inflammation, oxidative stress, and dermal damage simultaneously. Designed by dermatologists for professional use, Cutisma™ is suitable for resistant melasma, post-inflammatory hyperpigmentation, and dermal pigmentation. It is intended strictly for supervised clinical execution.

​

Cutisma™ is built on the understanding that pigmentation disorders are multifactorial and biologically persistent, requiring more than surface-level lightening. By integrating exosomes, PDRN, and peptides, the system supports cellular communication, dermal regeneration, and repair of pigment-altered skin. The sequential protocol helps stabilize melanocyte behavior before introducing aggressive pigment modulators, reducing the risk of rebound or irritation.

 

Cutisma™ is designed to work across epidermal and dermal pigment components, making it suitable for chronic and relapsing cases. The system allows dermatologists to maintain control over dosing, timing, and treatment intensity. It can be positioned as a standalone depigmentation protocolor integrated into combination treatment plans. Cutisma™ emphasizes skin quality restoration alongside pigment correction, aligning outcomes with long-term clinical stability rather than short-term cosmetic improvement.